FDA warns of rare vision-loss side effect from GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
Watch CBS News
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
According to the American College of Obstetricians and Gynecologists, women should stop taking the weight-loss drug one to two months before conception. Doctors say that because the drugs reduce appetite, women may not consume enough nutrients for the baby.
Going on GLP-1 drugs significantly boosted unemployed women's chances of finding a job, according to a Harvard economist.
Some very young Childhood obesity rates have soared to record highs since the pandemic.
According to a Wall Street Journal report, specialty stores are struggling to keep up with brides' fluctuating sizes, causing expensive alterations to wedding dresses when brides lose weight.